Novartis Prize for therapy-relevant immunological research goes to CRC 1160 scientist

Basic immunological research has a high potential for the development of innovative immunotherapeutic approaches. The successful translation of new findings from immunology is still a great challenge and requires a high degree of interdisciplinarity. Therefore, the German Society of Immunology in cooperation with the Novartis Foundation for Therapeutic Research awards the

Novartis Prize for immunological research relevant to therapy

This €10,000 prize is intended to reward work that builds a bridge between immunological and clinical research.

We are happy to announce that the first Novartis Prize for Therapy-Relevant Research goes to PD Dr. Susana Minguet (B01) for her research on the molecular control of T cell responses enables improved CAR-T-cell therapy.

DGFI

Hartl FA, Beck-Garcìa E, Woessner NM, Flachsmann LJ, Cárdenas RMV, Brandl SM, Taromi S, Fiala GJ, Morath A, Mishra P, Yousefi OS, Zimmermann J, Hoefflin N, Köhn M, Wöhrl BM, Zeiser R, Schweimer K, Günther S, Schamel WW, Minguet S. 2020. Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function. Nat Immunol. 21(8):902-913. doi: 10.1038/s41590-020-0732-3.